Here are the 424B prospectus supplements from CXApp Inc. (CXAI) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow CXAI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CXAI filings page.
CXApp Inc. files a prospectus supplement registering the resale of up to 10,026,776 shares of common stock. The supplement also covers resale of up to 10,280,000 private placement warrants, 24,080,000 shares of common stock underlying warrants, and specified resale rights of Streeterville Capital under existing agreements.
The supplement incorporates a Form 8-K reporting that Nasdaq granted an additional compliance period through September 7, 2026 to meet the $1.00 minimum bid price requirement; the company reported closing prices of $0.21 per share and $0.066 per warrant on March 11, 2026.
CXApp Inc. filed a prospectus supplement covering the resale of up to 10,026,776 shares of common stock, 10,280,000 warrants, and 24,080,000 shares of common stock underlying those warrants by selling securityholders. The supplement incorporates a Current Report on Form 8-K.
The attached Form 8-K discloses that CXApp issued 4,616,481 shares of common stock to Avondale Capital, LLC under a pre-paid purchase agreement at $0.24024 per share, with issuances on January 26, 27 and 28, 2026, relying on the private offering exemption in Section 4(a)(2) of the Securities Act. CXApp’s common stock and warrants trade on Nasdaq under the symbols CXAI and CXAIW, with recent closing prices of $0.305 per share and $0.0327 per warrant, respectively.
CXApp Inc. has filed a prospectus supplement covering the resale of up to 10,026,776 shares of common stock, along with 10,280,000 warrants and 24,080,000 shares of common stock underlying those warrants by existing securityholders. The supplement incorporates a new current report and must be read together with the base prospectus dated October 3, 2024.
Separately, CXApp disclosed that it issued 3,266,615 shares of common stock to Avondale Capital, LLC under a pre-paid purchase arrangement, at a price of $0.348985 per share, in a private offering relying on an exemption from registration. The company’s common stock and warrants trade on Nasdaq under the symbols CXAI and CXAIW, with recent closing prices of $0.4654 per share and $0.0778 per warrant.
CXApp Inc. filed a prospectus supplement for the resale of up to 10,026,776 shares of common stock, together with 10,280,000 warrants and 24,080,000 shares issuable upon warrant exercise, by selling securityholders. Components include 6,977,776 previously issued shares, 10,280,000 private placement warrants, 13,800,000 public-warrant shares and 10,280,000 private-warrant shares, plus up to 40,000 shares and up to 3,009,000 shares related to a May 22, 2024 financing.
The supplement attaches CXApp’s quarterly report. For the quarter ended September 30, 2025, revenue was $1.114 million versus $1.897 million a year ago, with a net loss of $3.157 million versus $5.434 million. Cash and cash equivalents were $5.088 million. Management disclosed recurring losses and cash use that raise doubt about continuing as a going concern, while citing financing arrangements and cost actions to support operations. As of November 11, 2025, shares outstanding were 28,629,315.
CXApp’s securities trade on Nasdaq as CXAI (common) and CXAIW (warrants).